Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer - PubMed (original) (raw)
Affiliations
- PMID: 9815967
Comparative Study
Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer
M F Di Renzo et al. Clin Cancer Res. 1995 Feb.
Abstract
The c-met oncogene encodes the receptor for hepatocyte growth factor/scatter factor, a potent mitogen for epithelial cells that also promotes cell motility and invasiveness. We have studied the changes of c-met gene expression that occur during the progression of colorectal tumors. Sixteen adenomas, 123 primitive carcinomas, and 25 liver metastases were examined. In several instances it was possible to compare same-patient samples of normal colon mucosa against primary tumor and primary carcinoma against synchronous metastasis. The expression of the c-met gene was increased from 5- to 50-fold in about 50% of tumors, at any stage of progression, and in 70% of liver metastases. Overexpression was associated with amplification of the c-met gene in only 10% of carcinomas, but in 8 of 9 metastases examined. These data suggest that overexpression of the c-met oncogene contributes a selective growth advantage to neoplastic colorectal cells at any stage of tumor progression. Moreover, amplification appears to give a further selective advantage for the acquisition of metastatic potential.
Similar articles
- Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M. Kataoka H, et al. Cancer Res. 2000 Nov 1;60(21):6148-59. Cancer Res. 2000. PMID: 11085539 - Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells.
Herynk MH, Stoeltzing O, Reinmuth N, Parikh NU, Abounader R, Laterra J, Radinsky R, Ellis LM, Gallick GE. Herynk MH, et al. Cancer Res. 2003 Jun 1;63(11):2990-6. Cancer Res. 2003. PMID: 12782608 - Immunohistochemical expression of HGF, c-MET and transcription factor STAT3 in colorectal tumors.
Trovato M, Vitarelli E, Grosso M, Alesci S, Benvenga S, Trimarchi F, Barresi G. Trovato M, et al. Eur J Histochem. 2004 Jul-Sep;48(3):291-7. Eur J Histochem. 2004. PMID: 15590419 - c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
Christensen JG, Burrows J, Salgia R. Christensen JG, et al. Cancer Lett. 2005 Jul 8;225(1):1-26. doi: 10.1016/j.canlet.2004.09.044. Epub 2004 Nov 11. Cancer Lett. 2005. PMID: 15922853 Review.
Cited by
- c-MET as a potential therapeutic target and biomarker in cancer.
Sierra JR, Tsao MS. Sierra JR, et al. Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S21-35. doi: 10.1177/1758834011422557. Ther Adv Med Oncol. 2011. PMID: 22128285 Free PMC article. - HSF4 promotes tumor progression of colorectal cancer by transactivating c-MET.
Zhang W, Zhang X, Cheng P, Yue K, Tang M, Li Y, Guo Q, Zhang Y. Zhang W, et al. Mol Cell Biochem. 2023 May;478(5):1141-1150. doi: 10.1007/s11010-022-04582-2. Epub 2022 Oct 13. Mol Cell Biochem. 2023. PMID: 36229759 - Quantification of the binding potential of cell-surface receptors in fresh excised specimens via dual-probe modeling of SERS nanoparticles.
Sinha L, Wang Y, Yang C, Khan A, Brankov JG, Liu JT, Tichauer KM. Sinha L, et al. Sci Rep. 2015 Feb 26;5:8582. doi: 10.1038/srep08582. Sci Rep. 2015. PMID: 25716578 Free PMC article. - Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Bauer TW, Fan F, Liu W, Johnson M, Parikh NU, Parry GC, Callahan J, Mazar AP, Gallick GE, Ellis LM. Bauer TW, et al. Ann Surg. 2005 May;241(5):748-56; discussion 756-8. doi: 10.1097/01.sla.0000160699.59061.92. Ann Surg. 2005. PMID: 15849510 Free PMC article. - Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.
Vermeulen L, De Sousa E Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, Sprick MR, Kemper K, Richel DJ, Stassi G, Medema JP. Vermeulen L, et al. Nat Cell Biol. 2010 May;12(5):468-76. doi: 10.1038/ncb2048. Epub 2010 Apr 25. Nat Cell Biol. 2010. PMID: 20418870
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous